Syncope Treatment
Treatment of syncope must be tailored to the underlying cause, with vasovagal syncope managed primarily through patient education and physical counterpressure maneuvers, orthostatic hypotension treated with acute water ingestion and pharmacotherapy (midodrine, droxidopa, or fludrocortisone), and cardiac syncope requiring urgent specialist evaluation and device therapy when indicated.
Vasovagal Syncope (VVS)
First-Line Management (Class I)
Patient education on diagnosis and prognosis is the cornerstone of treatment 1, 2. Most patients require only reassurance after specialist evaluation, as VVS carries no mortality risk 3.
Non-Pharmacological Interventions
Physical counterpressure maneuvers (PCMs) are recommended for patients with adequate prodromal warning (Class IIa) 1, 4:
- Leg crossing with tensing of leg, abdominal, and buttock muscles
- Squatting when symptoms begin
- Arm tensing (gripping hands and pulling in opposite directions)
- These maneuvers increase blood pressure and can abort impending syncope 4
- Lower-body PCMs may be preferable to upper-body maneuvers 4
Lifestyle modifications (Class IIb) 1:
- Increased salt and fluid intake (unless contraindicated by hypertension or heart failure)
- Avoidance of triggers (prolonged standing, hot environments, volume depletion)
- Withdrawal or reduction of hypotensive medications when appropriate
Orthostatic (tilt) training has uncertain benefit (Class IIb) and is limited by poor long-term compliance 1, 3.
Pharmacological Therapy
Midodrine is the first-line pharmacological agent (Class IIa) for patients with recurrent VVS who have no history of hypertension, heart failure, or urinary retention 1, 5. It provides dose-dependent improvement but may cause supine hypertension, scalp tingling, and urinary retention 6.
Fludrocortisone might be reasonable (Class IIb) for patients with inadequate response to salt and fluid intake, unless contraindicated 1. Side effects include edema, hypokalemia, and at doses >0.3 mg daily, potential adrenal suppression 6.
Beta-blockers might be reasonable (Class IIb) only in patients ≥42 years old with recurrent VVS 1, 2. However, the European guidelines give beta-blockers a Class III recommendation (not indicated) based on multiple negative long-term controlled trials 7, 8. This represents a significant divergence between guidelines.
Selective serotonin reuptake inhibitors might be considered (Class IIb) in recurrent cases 1.
Device Therapy
Dual-chamber pacing might be reasonable (Class IIb) in highly selected patients ≥40 years old with recurrent VVS and prolonged spontaneous pauses documented on monitoring 2.
Neurogenic Orthostatic Hypotension
Immediate Management (Class I)
Acute water ingestion (≥480 mL) is recommended for occasional, temporary relief 6, 1. The pressor effect peaks at 30 minutes and is sympathetically mediated. Avoid adding glucose or salt, which may reduce effectiveness 6.
Non-Pharmacological Interventions (Class IIa)
Physical counterpressure maneuvers (leg crossing, squatting, maximal handgrip) increase blood pressure, with squatting providing the largest effect 6, 1.
Compression garments should be at least thigh-high and preferably include the abdomen; shorter garments are not beneficial 6, 1.
Pharmacological Therapy (All Class IIa)
Midodrine improves symptoms with dose-dependent blood pressure increase. Limited by supine hypertension, scalp tingling, piloerection, and urinary retention 6, 1.
Droxidopa improves symptoms in Parkinson disease, pure autonomic failure, and multiple system atrophy. May reduce falls. Carbidopa in Parkinson patients may decrease droxidopa effectiveness. Side effects include supine hypertension, headache, dizziness, and nausea 6, 1.
Fludrocortisone increases plasma volume. Use other medications first if supine hypertension is present. Common side effects: edema, hypokalemia, headache 6, 1.
Refractory Cases (Class IIb)
- Pyridostigmine for patients refractory to other treatments 1
- Octreotide for refractory postprandial or neurogenic orthostatic hypotension 1
Increased salt and fluid intake may be reasonable in selected patients (Class IIb) 6, 1.
Situational Syncope
Treatment relies primarily on avoidance or elimination of triggering events 6, 1. When avoidance is impossible:
- Increase fluid and salt consumption
- Reduce or remove hypotensive drugs and diuretics (when safe) 6, 1
- Investigate for reversible underlying causes 1
Carotid Sinus Syndrome
Permanent cardiac pacing is reasonable (Class IIa) in patients with cardioinhibitory or mixed carotid sinus syndrome 1, 2.
Dual-chamber pacing may be reasonable (Class IIb) for those requiring permanent pacing 1.
Cardiac Syncope
Arrhythmic Causes
Urgent specialist cardiovascular assessment is mandatory for suspected cardiac arrhythmia, structural heart disease, or inherited cardiac conditions (long QT syndrome, Brugada syndrome) 9.
Long QT Syndrome (Class I):
- Beta-blocker therapy is first-line for suspected arrhythmic syncope 2
- ICD implantation is reasonable if syncope persists on beta-blockers or if beta-blockers are not tolerated (Class IIa) 2
Brugada Syndrome:
- ICD implantation is reasonable for syncope of suspected arrhythmic etiology (Class IIa) 2
Structural Heart Disease
Patients with LV dysfunction <35% and unexplained syncope frequently require ICD therapy after excluding common reversible causes 10.
Dehydration-Related Syncope
Fluid resuscitation via oral or intravenous bolus is recommended (Class I) for acute dehydration 1, 2.
Critical Pitfalls
- Do not perform electroencephalography in patients with clear syncope history, even if brief seizure activity occurred during the faint 9
- Do not use beta-blockers as first-line therapy for VVS given conflicting evidence and potential to worsen cardioinhibitory responses 7, 8
- Avoid supine hypertension when using vasopressor agents; monitor blood pressure in both positions 6
- Do not use patient-activated event recorders for syncope evaluation; they are inappropriate as patients cannot activate them during loss of consciousness 9
- Recognize that structural heart disease patients may have multiple syncope mechanisms (vasovagal, orthostatic hypotension, arrhythmia) requiring comprehensive evaluation 9